Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study

Published:2020-09 Issue: Volume:89 Page:87-95
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Li Hongmin,Ji Jiang,Du Yali,Huang Yuzhou,Gu Hao,Chen Miao,Wu RunHui,Han Bing

Funder

Beijing Natural Science Foundation

Chinese Academy of Medical Sciences (CAMS) Innovation for Medical Sciences

Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference23 articles.

1. Diagnosis and management of autoimmune cytopenias in childhood;Teachey;Pediatr Clin North Am,2013

2. Common variable immunodeficiency and autoimmunity—an inconvenient truth;Xiao;Autoimmun Rev,2014

3. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations;De Back;Expert Rev Hematol,2018

4. How I manage Evans syndrome and AIHA cases in children;Miano;Br J Haematol,2016

5. New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children;Aladjidi;Haematologica,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus is effective and safe in childhood relapsed‐refractory autoimmune cytopenias: A multicentre study;Scandinavian Journal of Immunology;2024-05-13

2. Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study;Annals of Hematology;2024-05-01

3. Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study;Blood Coagulation & Fibrinolysis;2024-04-15

4. HIF-1α induced by hypoxic condition regulates Treg/Th17 axis polarization in chronic immune thrombocytopenia;International Immunopharmacology;2024-04

5. Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations;Pediatric Drugs;2024-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3